Urticarial vasculitis is an autoimmune condition that causes itchy or painful hives. Some people may also develop inflammation in other organs, such as the kidneys or lungs. Vasculitis is a group of ...

Medically reviewed by Susan Bard, MD Key Takeaways Over-the-counter antihistamines are a common treatment for hives. Avoiding known triggers is key to managing acute hives.Seek emergency help if hives ...

Medically reviewed by Daniel More, MD Key Takeaways Hives can cause red, itchy bumps or welts on the skin.Hives might be ...

Learn to recognise chronic hives (urticaria), its symptoms, and how it differs from allergies for timely diagnosis and ...

Unlike allergic hives, chronic spontaneous urticaria (CSU) stems from immune system dysregulation and can persist for months or years, requiring ongoing management. Patients should understand that CSU ...

Patients with CSU have an elevated risk of anxiety and depression, necessitating comprehensive management strategies. Research is focused on identifying biomarkers and clinical characteristics to ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

The FDA approved oral remibrutinib (Rhapsido) as a second-line treatment for chronic spontaneous urticaria (CSU), or chronic hives, Novartis announced on Tuesday. Indicated for adults with stubborn ...

EAST HANOVER, N.J., Sept. 30, 2025 /PRNewswire/ -- Novartis announced today that Rhapsido ® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult ...